Assessing the transaminase complex-platelet ratio (TACPR) and the platelet-albumin ratio (PAR) as composite biomarkers in severe preeclampsia

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective analysis identifies TACPR as a predictive marker for preterm birth in severe preeclampsia patients, suggesting clinical utility.

TACPR significantly elevated in severe preeclampsia cases, and correlates with adverse outcomes such as preterm birth and low birth weight.
ROC analysis determined a TACPR cut-off of 0.86 with AUC of 0.701 for predicting preterm birth, indicating moderate predictive value.
A study involving 60 severe preeclampsia patients and 120 controls was conducted to assess the performance of TACPR and PAR in predicting outcomes.
Integration of TACPR into clinical assessments may improve risk stratification for women with severe preeclampsia, while PAR showed limited usefulness.

Okutucu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis identifies TACPR as a predictive marker for preterm birth in severe preeclampsia patients, suggesting clinical utility.